K
Kerecis
Develops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin
About Kerecis
Kerecis is a pioneering startup that operates in the healthcare sector, specifically in wound care. The company has developed an innovative solution for treating complex wounds, burns, and other acute and chronic wounds, including those resulting from diabetes, venous issues, trauma, and surgery. The treatment involves the use of intact fish skin, sourced from wild Atlantic cod caught in the pristine waters of Iceland. This fish skin is processed using renewable energy, underscoring the company's commitment to sustainability.
Read full description
The company's primary clients are patients suffering from stubborn wounds that are not healing properly. Kerecis has successfully treated thousands of patients across different income levels, cultures, and races, demonstrating the broad applicability and effectiveness of its solution. The story of Alana Smith, a real estate agent from Palo Alto, California, who was at risk of losing a limb due to a stubborn wound, is a testament to the company's impact. With Kerecis' treatment, her wound healed, saving her limb.
Kerecis operates in the global wound care market, which is a growing sector due to the increasing prevalence of chronic diseases such as diabetes. The company's business model involves the sale of its fish-skin treatment to healthcare providers, who then administer it to patients. This approach allows Kerecis to generate revenue while providing a much-needed solution to a pressing healthcare issue.
At a glance
- Founded
- 2010
- Headquarters
- Ísafjörður, Iceland
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning Kerecis.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Icelandic Centre for Research
Series B and later5 investors entered at this stage
Emerson Collective
Standard Treasury
HSBC Innovation Banking
KIRKBI
LSR
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
13 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kerecis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kerecis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.